CERO · Categories · Form 4

CERO - SEC Form 4 insider transactions

CERo Therapeutics Holdings Inc. (CERO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CERO

• 43d
  SEC Form 4 filed by Francois Eric

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Chief Development Officer Pierce Kristen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Director Patel Shami

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Director Rolfe Lindsey

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Director Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Director Byrnes Michael

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Chairman and CEO Ehrlich Christopher B

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 145d
  SEC Form 4 filed by Chief Financial Officer Kucharchuk Andrew Albert

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Director Byrnes Michael

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Director Rolfe Lindsey

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Director Patel Shami

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Chairman and CEO Ehrlich Christopher B

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Director Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Chief Development Officer Pierce Kristen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 366d
  SEC Form 4 filed by Chief Financial Officer Kucharchuk Andrew Albert

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 425d
  Director Atwood Brian G exercised 294,460 shares at a strike of $0.00 (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 454d
  SEC Form 4 filed by Director Patel Shami

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 454d
  SEC Form 4 filed by Director Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 454d
  SEC Form 4 filed by Director Rolfe Lindsey

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 454d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 454d
  SEC Form 4 filed by Director Byrnes Michael

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 454d
  SEC Form 4 filed by Chairman and CEO Ehrlich Christopher B

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 462d
  SEC Form 4 filed by Director Rolfe Lindsey

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 462d
  SEC Form 4 filed by Director Patel Shami

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 462d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 462d
  SEC Form 4 filed by Chairman and CEO Ehrlich Christopher B

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 462d
  SEC Form 4 filed by Director Byrnes Michael

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 462d
  SEC Form 4 filed by Director Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 481d
  SEC Form 4 filed by Director Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 537d
  Large owner Yk Bioventures Opportunities Gp I, Llc sold $400,456 worth of shares (5,957,250 units at $0.07) (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 540d
  Large owner Yk Bioventures Opportunities Gp I, Llc sold $383,370 worth of shares (3,658,364 units at $0.10) (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 546d
  SEC Form 4 filed by Chairman and CEO Ehrlich Christopher B

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 546d
  SEC Form 4 filed by Director Rolfe Lindsey

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 546d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 546d
  SEC Form 4 filed by Director Byrnes Michael

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 546d
  SEC Form 4 filed by Director Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 546d
  SEC Form 4 filed by Director Patel Shami

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 560d
  Large owner Sloan Stuart M sold $55,538 worth of shares (532,486 units at $0.10) (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 566d
  Large owner Yk Bioventures Opportunities Gp I, Llc sold $325,000 worth of shares (3,250,000 units at $0.10) (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 609d
  Director Laporte Kathleen converted options into 965,997 shares (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 609d
  Interim Chairman and CEO Ehrlich Christopher B converted options into 5,312,983 shares, increasing direct ownership by 1,110% to 5,791,808 units (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 609d
  Director Atwood Brian G converted options into 19,358,578 shares (SEC Form 4)

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 609d
  SEC Form 4 filed by Chief Financial Officer Kucharchuk Andrew Albert

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 609d
  SEC Form 4 filed by Chief Development Officer Pierce Kristen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 702d
  SEC Form 4 filed by Chief Financial Officer Carter Charles Ross

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Rolfe Lindsey

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Rapaport Robyn

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Laporte Kathleen

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Corey Daniel

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Carter Charles Ross

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Byrnes Michael

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 798d
  SEC Form 4 filed by Atwood Brian G

  4 - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)
• 814d
  Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)

  4/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Issuer)

Other CERO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends